ATE225771T1 - Prostaglandin-pharmazeutische-zusammensetzungen - Google Patents

Prostaglandin-pharmazeutische-zusammensetzungen

Info

Publication number
ATE225771T1
ATE225771T1 AT98934967T AT98934967T ATE225771T1 AT E225771 T1 ATE225771 T1 AT E225771T1 AT 98934967 T AT98934967 T AT 98934967T AT 98934967 T AT98934967 T AT 98934967T AT E225771 T1 ATE225771 T1 AT E225771T1
Authority
AT
Austria
Prior art keywords
pharmaceutical compositions
prostaglandin
prostaglandin pharmaceutical
compounds
general formula
Prior art date
Application number
AT98934967T
Other languages
English (en)
Inventor
Soldato Piero Del
Original Assignee
Nicox Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nicox Sa filed Critical Nicox Sa
Application granted granted Critical
Publication of ATE225771T1 publication Critical patent/ATE225771T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Cardiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
AT98934967T 1997-06-19 1998-06-17 Prostaglandin-pharmazeutische-zusammensetzungen ATE225771T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT97MI001440A IT1292377B1 (it) 1997-06-19 1997-06-19 Composizioni farmaceutiche a base di prostaglandine
PCT/EP1998/003645 WO1998058910A1 (en) 1997-06-19 1998-06-17 Prostaglandin pharmaceutical compositions

Publications (1)

Publication Number Publication Date
ATE225771T1 true ATE225771T1 (de) 2002-10-15

Family

ID=11377397

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98934967T ATE225771T1 (de) 1997-06-19 1998-06-17 Prostaglandin-pharmazeutische-zusammensetzungen

Country Status (19)

Country Link
US (1) US6211233B1 (de)
EP (1) EP0989972B1 (de)
JP (1) JP4394170B2 (de)
KR (1) KR20010013625A (de)
CN (1) CN1260778A (de)
AT (1) ATE225771T1 (de)
AU (1) AU740683B2 (de)
BR (1) BR9810163B1 (de)
CA (1) CA2292836C (de)
DE (1) DE69808619T2 (de)
DK (1) DK0989972T3 (de)
ES (1) ES2185188T3 (de)
HU (1) HUP0004071A3 (de)
IL (1) IL132690A (de)
IT (1) IT1292377B1 (de)
PT (1) PT989972E (de)
RU (1) RU2000100807A (de)
SI (1) SI0989972T1 (de)
WO (1) WO1998058910A1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9801398D0 (en) 1998-01-22 1998-03-18 Anggard Erik E Chemical compounds
AU3713600A (en) 1999-03-01 2000-09-21 Nitromed, Inc. Nitrosated and nitrosylated prostaglandins, compositions and metods of use
IT1311923B1 (it) 1999-04-13 2002-03-20 Nicox Sa Composti farmaceutici.
IT1319201B1 (it) * 2000-10-12 2003-09-26 Nicox Sa Farmaci per il diabete.
WO2002060387A2 (en) * 2001-01-30 2002-08-08 Pharmaceutical Research Corporation Use of prostaglandin analogs for treatment of cardiac conditions
GB0111872D0 (en) * 2001-05-15 2001-07-04 Northwick Park Inst For Medica Therapeutic agents and methods
US7968605B2 (en) * 2002-02-04 2011-06-28 ALFAMA—Investigação e Desenvolvimento de Produtos Farmacêuticos, Lda. Methods for treating inflammatory disease by administering aldehydes and derivatives thereof
US20080026984A1 (en) * 2002-02-04 2008-01-31 Alfama - Investigacao E Desenvolvimento De Productos Farmaceuticos Lda Methods for treating inflammatory disease by administering aldehydes and derivatives thereof
EP2319518A1 (de) * 2002-02-04 2011-05-11 ALFAMA-Investigacao e Desenvolvimento de Produtos Farmaceuticos Lda. Verwendung CO-freisetzender Verbindungen zur Behandlung entzündlicher Erkrankungen
US20060247216A1 (en) * 2002-10-25 2006-11-02 Haj-Yehia Abdullah I Steroid compounds comprising superoxide dismutase mimic groups and nitric oxide donor groups, and their use in the preparation of medicaments
GB2395432B (en) * 2002-11-20 2005-09-14 Northwick Park Inst For Medica Therapeutic delivery of carbon monoxide to extracorporeal and isolated organs
US20070207217A1 (en) * 2003-02-03 2007-09-06 Alfama - Investigacao E Desenvolvimento De Productos Farmaceuticos Lda Method for treating a mammal by administration of a compound having the ability to release CO
EP3643702A1 (de) * 2004-01-05 2020-04-29 Nicox S.A. Prostaglandinderivate
JP2009501150A (ja) * 2005-06-29 2009-01-15 ファイザー・インク プロスタグランジン誘導体
JP2009500315A (ja) * 2005-06-29 2009-01-08 ファイザー・インク フルオロプロスタグランジンのニトロ誘導体
GB0601394D0 (en) 2006-01-24 2006-03-01 Hemocorm Ltd Therapeutic delivery of carbon monoxide
EP2007705A4 (de) * 2006-03-29 2011-09-07 Nicox Sa Stickstoffmonoxid verstärkende prostaglandinverbindungen, zusammensetzung und anwendungsverfahren
US8041859B2 (en) * 2007-11-05 2011-10-18 Honywell International Inc. Apparatus and method for connectivity in networks capable of non-disruptively disconnecting peripheral devices
ES2656237T3 (es) 2011-04-19 2018-02-26 Alfama, Inc. Moléculas liberadoras de monóxido de carbono y usos de las mismas
WO2013013179A1 (en) 2011-07-21 2013-01-24 Alfama, Inc. Ruthenium carbon monoxide releasing molecules and uses thereof
WO2014111957A1 (en) 2013-01-21 2014-07-24 Apparao Satyam Nitric oxide releasing prodrugs of therapeutic agents
CN113943266A (zh) * 2021-11-18 2022-01-18 广州楷石医药有限公司 一种氧化氮供体型贝前列素类衍生物及其药物组合物和用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0102230B1 (de) * 1982-08-24 1987-04-29 Teijin Limited 6-Nitroprostaglandinderivate, Verfahren zu ihrer Herstellung und ihre Anwendung
SE463851B (sv) 1988-09-02 1991-02-04 Amsu Ltd Komposition foer behandling av erektil dysfunktion via uretra
IT1243367B (it) 1990-07-26 1994-06-10 Italfarmaco Spa Derivati acidi benzoici sostituiti ad attivita' cardiovascolare
US5352708A (en) * 1992-09-21 1994-10-04 Allergan, Inc. Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
US5328933A (en) * 1992-10-28 1994-07-12 Allergan, Inc. Cyclopentane heptenylnitro and heptanylnitro-2-aliphatic or aryl aliphatic derivatives and homologues
KR100387359B1 (ko) * 1994-05-10 2003-08-27 니콕스 에스. 에이. 항-염증성,비알러지성및항-혈전성을가지는니트로화합물들과그들의조성물들
US5625083A (en) * 1995-06-02 1997-04-29 Bezuglov; Vladimir V. Dinitroglycerol esters of unsaturated fatty acids and prostaglandins

Also Published As

Publication number Publication date
DE69808619D1 (de) 2002-11-14
DE69808619T2 (de) 2003-06-12
IT1292377B1 (it) 1999-02-08
IL132690A (en) 2004-06-01
AU8438698A (en) 1999-01-04
ITMI971440A1 (it) 1998-12-19
BR9810163A (pt) 2000-08-08
WO1998058910A1 (en) 1998-12-30
DK0989972T3 (da) 2003-02-10
EP0989972A1 (de) 2000-04-05
US6211233B1 (en) 2001-04-03
ITMI971440A0 (de) 1997-06-19
SI0989972T1 (en) 2003-04-30
CN1260778A (zh) 2000-07-19
KR20010013625A (ko) 2001-02-26
CA2292836C (en) 2010-03-02
HUP0004071A3 (en) 2002-12-28
EP0989972B1 (de) 2002-10-09
ES2185188T3 (es) 2003-04-16
IL132690A0 (en) 2001-03-19
RU2000100807A (ru) 2002-02-27
CA2292836A1 (en) 1998-12-30
HUP0004071A2 (hu) 2001-04-28
AU740683B2 (en) 2001-11-08
JP4394170B2 (ja) 2010-01-06
JP2002506440A (ja) 2002-02-26
BR9810163B1 (pt) 2009-01-13
PT989972E (pt) 2003-02-28

Similar Documents

Publication Publication Date Title
ATE225771T1 (de) Prostaglandin-pharmazeutische-zusammensetzungen
ATE306261T1 (de) Antithrombosemittel
PT1193270E (pt) Pirrolobenzodiazepinas
ATE297203T1 (de) Antithrombotische mitteln
DK0941218T3 (da) Antithrombotiske organiske nitrater
HN1998000036A (es) Compuesto de pirazina
EA199900373A2 (ru) Фармацевтические композиции
HN1999000125A (es) Nuevos derivados sustituidos del pirazol
BG103485A (en) Ketobanzamides as calpain inhibitors
NL1002835A1 (nl) Synergistisch stabilisatormengsel.
HN1999000131A (es) Derivados del acido hidroxi pipecolato hidroxamico.
EA200300937A1 (ru) Оральная фармацевтическая композиция цефподоксима проксетила
PT1307455E (pt) Inibidores de adesao celular mediada por (alfa)l (beta)2
BR0206595A (pt) Composto, composição farmacêutica, e uso de um composto
SE9901077D0 (sv) Novel use
ATE235462T1 (de) Metalloproteinase-inhibitoren
HN1998000045A (es) Composiciones farmaceuticas
DK1206452T3 (da) Fremgangsmåde til fremstilling af benzoperhydro-isoindolforbindelser
HN1998000102A (es) Composiciones solubilizadas de sertralina
DK0745081T3 (da) Indan-2-mercaptoacetylamiddisulfidderivater, der er anvendelige som enkephalinase-inhibitorer
DK0915858T3 (da) Mellemprodukter til fremstilling af 2-imidazolin-5-oner
BR9912885A (pt) Derivado de 3-azabiciclo-[3.2.0]- heptano n-substituìdo
GT199900160A (es) Compuestos plaguicidas de bis-oxima.
UY24326A1 (es) Nuevas piperidinas.
HN1999000205A (es) Formulaciones antiparasitos

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0989972

Country of ref document: EP